KLOW Blend Vial 80mg
KLOW Blend Vial 80mg — a research-grade blend of four studied peptides in a single vial: BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg), and KPV (10mg). Supplied as a lyophilized powder for laboratory research use only. HPLC-tested with a lot-specific Certificate of Analysis reporting each component.
$142.99
Research goals: Recovery & Healing
Description
Important Note on the Evidence Base
There is no published research on this specific four-peptide combination as a fixed formulation. Combination effects are not established in the literature. Every study cited here was conducted on a single component individually. All are preclinical (animal and in-vitro models). KLOW is not approved by the FDA for any use.
The Four Components
BPC-157 (10mg)
A synthetic 15-amino-acid peptide derived from a gastric-juice protein fragment. Its preclinical literature centers on angiogenesis and tissue-repair research in rodent injury models — tendon, ligament, and gastrointestinal.123
TB-500 (10mg)
A synthetic acetylated fragment corresponding to the actin-binding region of thymosin β4. Studied in cell-migration and tissue-repair research, including cardiac and corneal models.456
GHK-Cu (50mg)
A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) studied in skin, extracellular-matrix, and wound-remodeling research.789
KPV (10mg)
The C-terminal tripeptide of α-MSH, studied in anti-inflammatory research, principally intestinal-inflammation models.1011
Research Rationale for the Combination
Blends like KLOW combine peptides whose individual literatures span complementary research domains — tissue repair (BPC-157, TB-500), extracellular-matrix and skin research (GHK-Cu), and anti-inflammatory signaling (KPV). Researchers should note the published research on each component was conducted with that peptide alone; this specific combination has not been studied.
Product Specifications
- Format: lyophilized powder in vial (reconstitute with bacteriostatic water)
- Total: 80mg per vial (BPC-157 10mg / TB-500 10mg / GHK-Cu 50mg / KPV 10mg)
- Purity: each component ≥99% (RP-HPLC verified)
- Certificate of Analysis: lot-specific COA reports quantity + purity of each component
For per-component research and full citations, see the KLOW research hub.
Research use only. Not for human or animal consumption. Not a drug, supplement, or medical product.
References
- Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017;95(3):323-333. PMID: 27847966
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing. J Appl Physiol. 2011;110(3):774-780. PMID: 21030672
- Cerovecki T, et al. Pentadecapeptide BPC 157 improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-1161. PMID: 20225319
- Goldstein AL, et al. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429.
- Bock-Marquette I, et al. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-472.
- Sosne G, et al. 0.1% RGN-259 (Thymosin β4) ophthalmic solution: a randomized, placebo-controlled, double-masked Phase III trial. Int J Mol Sci. 2022;24(1):554. PMID: 36613994
- Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.
- Badenhorst T, et al. Physicochemical characterization of native GHK tripeptide for wound healing and anti-aging. Pharm Dev Technol. 2016;21(2):152-160.
- Miller TR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-259.
- Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. PMID: 18061177
- Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine IBD models. Inflamm Bowel Dis. 2008;14(3):324-331.
Reconstitution calculator
Pre-loaded with this vial's available strengths: 80 mg.
The total peptide mass printed on the vial label.
Bacteriostatic water or other diluent added to the vial.
Resulting concentration
Enter a vial mass and diluent volume
Mass per volume
| Volume | Contains |
|---|
Volume for a given mass
Enter a mass to find the volume of this solution that contains it.
Volume and mass are not the same thing. The same volume drawn from two differently-reconstituted vials contains different amounts of peptide — concentration is what links them.
The total peptide mass printed on the vial label.
The concentration you want the reconstituted solution to be.
Diluent volume required
Enter a vial mass and target concentration
Useful when matching concentration across vials of different strengths, or standardising a solution to a fixed working concentration.
Preparation and storage
Research-only handling information. KLOW is sold strictly for in vitro laboratory research. The handling and storage guidance below reflects standard practice in published peptide research literature. KLOW is not a drug, supplement, or food product, and is not for human consumption, veterinary use, or medical applications.
Format
- Form: Vial (lyophilized powder)
- Total: 80mg (BPC-157 10mg / TB-500 10mg / GHK-Cu 50mg / KPV 10mg)
- Verified purity: each component >99% (RP-HPLC)
- Documentation: Batch-specific Certificate of Analysis (COA) included
Reconstitution for Research Use
KLOW is supplied as a sterile, lyophilized powder. Reconstitution with bacteriostatic water (BAC water) is the standard preparation step used in published research protocols. The volume of BAC water used determines the total and per-component concentrations.
Example (for the 80mg total reconstituted in 4 mL of BAC water):
- Total peptide: 80mg · BAC water added: 4 mL · Total concentration: ~20 mg/mL
- Per component at 4 mL: BPC-157 ~2.5 mg/mL, TB-500 ~2.5 mg/mL, GHK-Cu ~12.5 mg/mL, KPV ~2.5 mg/mL
Recommended practice (same as single peptides):
- Use sterile bacteriostatic water (0.9% benzyl alcohol) for reconstitution.
- Allow the lyophilized powder to reach room temperature before opening the vial.
- Inject the BAC water against the inside wall of the vial — do not aim the stream directly at the lyophilized cake.
- Gently swirl the vial until the powder is fully dissolved. Do not shake.
- Once reconstituted, store the vial under refrigeration at 4 °C (39 °F).
See the reconstitution math guide for concentration calculations.
Storage & Handling
- Lyophilized: 2–8 °C short term; −20 °C for long-term storage.
- Reconstituted: 2–8 °C, used within the protocol's stability window.
- Handling: minimize freeze/thaw cycles; protect from light and heat.
Important Notice
All Omnix Peptides products are sold for laboratory, research, or analytical purposes only. They are not for human consumption, veterinary use, or medical applications. Researchers and laboratory professionals must follow all applicable institutional, local, state, and federal regulations governing the handling of research compounds.
Citations
Citations and reference data. The references below cite published preclinical research on the individual components. There is no published research on the KLOW combination itself. These are not clinical evidence in humans, and KLOW is not approved by the FDA or any other regulatory authority for any indication.
Compound Reference Data (per component)
- BPC-157 — CAS 137525-51-0 · Formula C62H98N16O22 · MW 1419.55 g/mol · Sequence GEPPPGKPADDAGLV
- TB-500 — CAS 885340-08-9 · Formula C38H68N10O14 · MW 889.02 g/mol · Sequence Ac-LKKTETQ
- GHK-Cu — CAS 89030-95-5 (Cu complex) · Formula C14H23CuN6O4 · MW 402.91 g/mol · Sequence Gly-His-Lys:Cu
- KPV — CAS 67727-97-3 · Formula C16H30N4O4 · MW ~342.4 g/mol · Sequence Lys-Pro-Val
Selected Published Studies (by component)
The following peer-reviewed studies were conducted using animal models or in vitro cell-culture systems, each on a single component individually. None should be interpreted as recommending KLOW or any component for human use, treatment, or any clinical purpose.
- BPC-157 — Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017;95(3):323-333. PMID: 27847966
- BPC-157 — Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing. J Appl Physiol. 2011;110(3):774-780. PMID: 21030672
- BPC-157 — Cerovecki T, et al. Pentadecapeptide BPC 157 improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-1161. PMID: 20225319
- TB-500 — Goldstein AL, et al. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429.
- TB-500 — Bock-Marquette I, et al. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-472.
- TB-500 — Sosne G, et al. 0.1% RGN-259 (Thymosin β4) ophthalmic solution: a randomized, placebo-controlled, double-masked Phase III trial. Int J Mol Sci. 2022;24(1):554. PMID: 36613994
- GHK-Cu — Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.
- GHK-Cu — Badenhorst T, et al. Physicochemical characterization of native GHK tripeptide for wound healing and anti-aging. Pharm Dev Technol. 2016;21(2):152-160.
- GHK-Cu — Miller TR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-259.
- KPV — Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. PMID: 18061177
- KPV — Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine IBD models. Inflamm Bowel Dis. 2008;14(3):324-331.
Evidence-Base Disclosure
KLOW has no independent research literature. The evidence base is the separate preclinical literature of its four components, each studied individually in animal and in-vitro models. No study establishes combination effects. Full per-component citations live on each component's research hub.
Frequently asked questions
Frequently asked questions about the KLOW Blend Vial. Questions on this page cover composition, handling, storage, documentation, and ordering. KLOW is sold for laboratory, research, or analytical purposes only — not for human consumption, veterinary use, or medical applications.
What is KLOW?
A research-grade blend of four peptides — BPC-157, TB-500, GHK-Cu, and KPV — in a single vial for laboratory research use only.
Is there research on KLOW specifically?
No. KLOW is a blend; there is no published research on this specific four-peptide combination. The relevant research is the separate literature on each component, linked from the KLOW research hub.
What are the quantities of each peptide in KLOW?
Per 80mg vial: BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, KPV 10mg. See the lot-specific COA for measured quantities.
How is the KLOW Vial prepared for laboratory research?
Supplied as sterile lyophilized powder; reconstitute with bacteriostatic water. Volume added sets the total and per-component concentrations. See the Preparation & Storage tab.
How is KLOW stored and handled?
Lyophilized at 2–8 °C short term or −20 °C long term; reconstituted at 2–8 °C. Minimize freeze/thaw; protect from light and heat.
Is KLOW approved by the FDA?
No. Not approved by the FDA or any authority for any indication. Sold strictly for laboratory, research, or analytical purposes.
What is included with each KLOW Vial?
The sealed container and a batch-specific COA reporting quantity + purity of each of the four components by HPLC. Full COA library: /coa-lab-reports/.
How does Omnix Peptides ship orders?
Ships from a US facility with tracked domestic shipping. Free shipping over $199. Lyophilized vials ship at ambient temperature; tracking emailed after shipment.
What if my product arrives damaged or the seal is broken?
Contact Omnix within 48 hours of delivery. Transit damage or a compromised seal is replaced at no cost. See /shipping-return-policy/.
Customer reviews
Certificate of Analysis
Third-party HPLC purity analysis performed by an independent laboratory for this batch.
Reviews
There are no reviews yet.